Modernatx, Inc.

Modernatx, Inc.

Modernatx, Inc.

Date Founded



200 Technology Square,Cambridge, MA 02141

Type of Company




Company Description

Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.

Executives & Employees

Chief Executive Officer


General Counsel & Corporate Secretary

Chief Scientific Officer

Chief Human Resources Officer

Chief Corporate Affairs Officer


Chief Technical Operations & Quality Officer

Head of Talent Management

Chief Medical Officer

Board of Directors

Chairman & Co-Founder at Moderna, Inc.

Founder at Alnylam Pharmaceuticals, Inc.

Director & Chief Executive Officer at Moderna, Inc.

Executive Vice President for Strategy at ModeX Therapeutics

Managing Partner at Flagship Pioneering

Investment Team at General Catalyst LLC

Former Chief Financial Officer & Treasurer at MIT Corp. (United States)

Paths to Modernatx, Inc.
Potential Connections via
Relationship Science
Modernatx, Inc.
Advisors & Consultants

Founder at Fate Therapeutics, Inc.

Legal Advisor

National Co-Chair, Life Sciences Practice at Goodwin Procter LLP

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Modernatx, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Modernatx, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Modernatx, Inc..